Worth Watching Stocks in Focus: Rite Aid Corporation (NYSE:RAD), Cemex SAB de CV (ADR) (NYSE:CX), AstraZeneca plc (ADR) (NYSE:AZN)

On Thursday, Shares of Rite Aid Corporation (NYSE:RAD), subtract -2.77% and closed at $7.37 in the last trading session. The last trading range of the stock ranges between $7.26 and $7.60. To celebrate American Pharmacist Month, Rite Aid is asking customers nationwide to recognize their favorite pharmacy team member through its thirteenth annual Vote for Your Favorite Pharmacy Team Member Contest. By submitting a nomination for their favorite Rite Aid pharmacy team member, customers have a chance to win $2,500 in Rite Aid gift cards. The contest was designed to recognize Rite Aid pharmacy associates counting pharmacists, pharmacy technicians, pharmacy managers, pharmacy cashiers and Wellness Ambassadors, for their commitment to providing excellent customer service.

“American Pharmacist Month is a great time to acknowledge the dedication of our pharmacy teams as they continue to assist our customers and their families lead healthy lives every day,” said Tammy Royer, Rite Aid senior vice president of pharmacy operations. “Our pharmacists, pharmacy technicians, wellness ambassadors and pharmacy cashiers are committed and dedicated to making a difference year-round in the lives of those in the communities we serve by providing unique services such as medication consultations or assisting patients find solutions to improve medication adherence.”

Cemex SAB de CV (ADR) (NYSE:CX), jumped 0.86 % and closed at $8.17 in the last trading session. The last trading range of the stock ranges between $7.99 and $8.20. The company’s Market capitalization is $11.72 Billion with the total Outstanding Shares of 0.00 Billion. Mexico’s Cemex said on Wednesday that it had designated a new chairman and chief executive for its Latam partner, after some former executives were fired amid investigations into improper payments regardinga land deal in Colombia.

Juan Pablo San Agustin was named chairman of the board of Cemex Latam Holdings, while Jaime Muguiro was named its new chief executive, Cemex said in a filing.

It also named Ricardo Naya as the director of Cemex Colombia.

Cemex said in September it had dismissed two senior executives and accepted the resignation of another after it found improper payments linked to a new cement plant in northern Colombia.source reuter

AstraZeneca plc (ADR) (NYSE:AZN), lost -1.14% and closed at $32.26in the last trading session. The last trading range of the stock ranges between $32.17 and $32.44. During the 52-week trading session the minimum price at which share price traded, registered at $26.97 and reached to max level of $35.04. AstraZeneca recently declared new data demonstrating that respiratory syncytial virus hospitalization (RSVH) rates raised significantly during the 2014-2015 RSV season among US infants <3 months of age born at 29-34 weeks gestational age (wGA), as contrast to the 2013-2014 season.1 RSV is a contagious, seasonal respiratory virus that can lead to a serious lung infection and hospitalization in high-risk babies, particularly preterm infants.2,3,4 These data are based on data from over 2.2 million US infants and represent the first and only analysis conducted using national US Medicaid and Commercial insurance claims databases to further understand the changes in both immunoprophylaxis (IP) utilization and RSVH rates. This research was presented as a poster (poster number J14) at the annual Academy of Managed Care Pharmacy (AMCP) Nexus meeting in National Harbor, MD.

Results showed that among <3 months old infants who were born at 29-34 wGA, RSVH rates raised by 170% and 40% within the commercial and Medicaid populations, respectively, during the 2014-2015 season when contrast to the prior season.

Leave a Reply

Your email address will not be published. Required fields are marked *